Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03716466 · ClinicalTrials.gov registry record
Evaluation of Prophylactic Endotracheal Intubation
A clinical trial of GastroIntestinal Bleeding and Intubation; Difficult, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 65
- Enrollment target
- 1
- Study location
NCT03716466: Completed study of GastroIntestinal Bleeding and Intubation; Difficult, sponsored by University of Texas Southwestern Medical Center.
NCT03716466 is a study of GastroIntestinal Bleeding and Intubation; Difficult that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 65 participants, below the 3,284-participant average among 4 other GastroIntestinal Bleeding trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03716466, a study of GastroIntestinal Bleeding and Intubation; Difficult, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
Upper gastrointestinal (GI) bleeding is defined as patients who either presented with hematemesis or presented with melena along with evidence of hemodynamic compromise. These patients have risk of aspiration of blood along with gastric content. The mortality rate can be 15% to 20% in the cases with variceal bleeding. From a practical standpoint, it is widely accepted that the best way to secure an airway during upper GI bleeding is prophylactic endotracheal intubation (PEI). The aim of this study is to determine the incidence of complications among critically ill patients with upper GI bleeding and received urgent endoscopy.
Primary Outcome
The number of cardiovascular unplanned event after upper gastrointestinal endoscopy, up to 48 hours
Conditions Studied
Interventions
- OTHER Endotracheal intubation
- OTHER No airway intervention
Study Locations (1)
Texas
- Parkland Health Hospital System - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2018-11-11 |
| Est. Completion | 2021-07-09 |
What the finished NCT03716466 record still lists
NCT03716466 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 3,284-participant average among 4 other GastroIntestinal Bleeding trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with GastroIntestinal Bleeding appearing as the primary indexed condition, and to 2 interventions - of which Endotracheal intubation is the first listed.
NCT03716466 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03716466 about?
NCT03716466 is a clinical study titled "Evaluation of Prophylactic Endotracheal Intubation". Upper gastrointestinal (GI) bleeding is defined as patients who either presented with hematemesis or presented with melena along with evidence of hemodynamic compromise. These patients have risk of aspiration of blood along with gastric content. The mortality rate can be 15% to 20% in the cases with...
What is the current status of trial NCT03716466?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2018-11-11. Estimated completion is 2021-07-09.
What conditions does trial NCT03716466 study?
This clinical trial studies the following conditions: GastroIntestinal Bleeding, Intubation; Difficult.
What interventions are being tested in trial NCT03716466?
The interventions under investigation include: Endotracheal intubation (OTHER), No airway intervention (OTHER).
Who is sponsoring clinical trial NCT03716466?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03716466 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for GastroIntestinal Bleeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
RECRUITING
-
Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding
RECRUITING
-
Marginal Ulcer Healing With Low-Thermal Argon Plasma Endoscopic Treatment
RECRUITING · NA
-
Study of Early Endocapsule (EC) in Clinical Decision Unit Versus Standard of Care Work-up for GI Bleeding
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI